Literature DB >> 19402102

Fetal dilated cardiomyopathy caused by persistent junctional reciprocating tachycardia.

J Cornette1, A D J ten Harkel, E A P Steegers.   

Abstract

Ultrasound examination of a fetus at 32 weeks' gestation revealed dilated cardiomyopathy and a heart rate of 170 beats per minute. Prenatally, this mild tachycardia was not primarily suspected to be the cause of the myocardial changes. Postnatal electrocardiography revealed a persistent junctional reciprocating tachycardia (PJRT) and the diagnosis of tachycardia-induced cardiomyopathy (TICM) became apparent. After conversion to a sinus rhythm under digoxin and amiodarone, the cardiac changes regressed. PJRT is a rare form of supraventricular tachycardia. The prenatal findings in the condition have previously been described retrospectively, but it can only be diagnosed postnatally by its characteristic electrocardiographic properties. This case indicates that TICM can occur at lower heart rates than previously assumed. Even severe prenatal cardiomyopathy may be reversible once sinus rhythm has been restored.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402102     DOI: 10.1002/uog.6364

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  Tachycardia-induced cardiomyopathy after functional closure of the foramen ovale in a fetus.

Authors:  Elisabeth Mlczoch; Ulrike Salzer-Muhar; Barbara Ulm; Manfred Marx
Journal:  Pediatr Cardiol       Date:  2011-02-25       Impact factor: 1.655

2.  Postnatal outcome in patients with fetal tachycardia.

Authors:  Shreya Moodley; Shubhayan Sanatani; James E Potts; George G S Sandor
Journal:  Pediatr Cardiol       Date:  2012-05-26       Impact factor: 1.655

3.  Rare Case of Fetal Permanent Junctional Reciprocating Tachycardia Refractory to Prenatal Antiarrhythmic Therapy.

Authors:  Kavita Narang; Carl H Rose; Jonathan N Johnson; Philip L Wackel; Frank Cetta
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.